Phase II trial of pemetrexed disodium (Alimta, LY231514) in chemotherapy-naive patients with advanced non-small cell lung cancer

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{78271f84149944c59a06e79ddc3e83c9,

title = "Phase II trial of pemetrexed disodium (Alimta, LY231514) in chemotherapy-naive patients with advanced non-small cell lung cancer",

author = "Michael Millward",

year = "2002",

language = "English",

volume = "13",

pages = "737--741",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}